CIK 0000842023 · Large accelerated filer
BIO-TECHNE Corp
Sign in to watch- Ticker
- TECH
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Jun 30
- Incorporated
- MN
- Entity type
- operating
- EIN
- 411427402
- Phone
- 612-379-8854
- Business address
- 614 MCKINLEY PLACE NE, MINNEAPOLIS, MN
- Former names
- TECHNE CORP /MN/
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-08-30 | Nusse Roeland Director | Option exercise | +16,000 | $22.95 | $367K | 60,811 |
| 2023-08-30 | Nusse Roeland Director | Sale | −8,939 | $80.32 | $718K | 51,872 |
| 2023-08-30 | Nusse Roeland Director | Option exercise · Stock Options (Right to Buy) | −16,000 | 0 | ||
| 2023-08-30 | Nusse Roeland Director | Option exercise · Stock Options (Right to Buy) | −16,000 | 0 | ||
| 2023-08-24 | Kelderman Kim Pres. Diagnostics & Genom | Option exercise | +2,100 | $47.60 | $100K | 21,225 |
| 2023-08-24 | Kelderman Kim Pres. Diagnostics & Genom | Option exercise · Stock Option (Right to Buy) | −2,100 | 109,536 | ||
| 2023-08-15 | Geist William PRESIDENT, PROTEIN SCIENCES | Grant or award · Restricted Stock Units | +9,074 | 9,074 | ||
| 2023-08-15 | Geist William PRESIDENT, PROTEIN SCIENCES | Grant or award · Stock Options (Right to Buy) | +24,424 | 24,424 | ||
| 2023-08-15 | Bohnen Shane SVP - General Counsel | Grant or award · Restricted Stock Units | +4,802 | 4,802 | ||
| 2023-08-15 | Bohnen Shane SVP - General Counsel | Grant or award · Stock Option (Right to Buy) | +12,924 | 12,924 | ||
| 2023-08-15 | Kelderman Kim Pres. Diagnostics & Genom | Grant or award · Restricted Stock Units | +8,873 | 8,873 | ||
| 2023-08-15 | Kelderman Kim Pres. Diagnostics & Genom | Grant or award · Stock Options (Right to Buy) | +23,881 | 23,881 | ||
| 2023-08-15 | Hippel James CFO | Grant or award · Restricted Stock Units | +13,865 | 13,865 | ||
| 2023-08-15 | Hippel James CFO | Grant or award · Stock Options (Right to Buy) | +37,314 | 37,314 | ||
| 2023-08-15 | Bohnen Shane SVP - General Counsel | Grant or award · Restricted Stock Units | +148 | 148 | ||
| 2023-08-15 | Bohnen Shane SVP - General Counsel | Grant or award · Stock Option (Right to Buy) | +16,302 | 16,302 | ||
| 2023-08-15 | Hippel James CFO | Grant or award · Restricted Stock Units | +12,798 | 12,798 | ||
| 2023-08-15 | Hippel James CFO | Grant or award · Stock Options (Right to Buy) | +34,442 | 34,442 | ||
| 2023-08-15 | Hippel James CFO | Grant or award · Stock Options (Right to Buy) | +45,923 | 45,923 | ||
| 2023-08-15 | Kelderman Kim Pres. Diagnostics & Genom | Grant or award · Restricted Stock Units | +8,191 | 8,191 |
Page 19 of 32 · 626 trades